Gene: TMEM267
Official Full Name: transmembrane protein 267provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13170 | TMEM267 Knockout cell line (HeLa) | Human | TMEM267 | 1:3~1:6 | Negative | Online Inquiry |
KO13171 | TMEM267 Knockout cell line (HCT 116) | Human | TMEM267 | 1:2~1:4 | Negative | Online Inquiry |
KO13172 | TMEM267 Knockout cell line (HEK293) | Human | TMEM267 | 1:3~1:6 | Negative | Online Inquiry |
KO13173 | TMEM267 Knockout cell line (A549) | Human | TMEM267 | 1:3~1:4 | Negative | Online Inquiry |
TMEM267 Gene Knockout Cell Lines are genetically modified cell models specifically designed to elucidate the role of the TMEM267 gene in various biological processes. These knockout strains represent an invaluable tool for researchers aiming to study gene function, signaling pathways, and cellular mechanisms by providing a system in which the TMEM267 protein is completely absent. The absence of this gene allows for the precise analysis of downstream effects and compensatory mechanisms that might otherwise obscure the understanding of its biological significance.
The primary function of these cell lines is to facilitate the investigation of TMEM267's role in cellular phenotypes, such as differentiation, proliferation, and apoptosis. At the mechanistic level, researchers can dissect the influence of TMEM267 loss on various signaling pathways, thereby gaining insights into its relevance in disease states, including cancer and metabolic disorders. Such detailed studies are critical for advancing our understanding of genetic influences on health and disease.
In terms of scientific importance, TMEM267 Gene Knockout Cell Lines act as a pivotal resource in both research and clinical settings. They offer the potential for validating hypotheses regarding gene function and exploring therapeutic targets. Furthermore, understanding the implications of TMEM267 in human health could lead to novel interventions for conditions linked to its dysregulation.
Compared to alternative products, TMEM267 Gene Knockout Cell Lines provide an unparalleled specificity in studying this particular gene without the confounding variables associated with partial knockdowns or alternative methods of gene manipulation. They are derived from reliable cellular backgrounds that ensure reproducibility and ease of use, making them accessible for a range of applications.
For researchers and clinicians, the value of TMEM267 Gene Knockout Cell Lines lies not only in their precision and reliability but also in their ability to enhance current knowledge around gene functionality, which is vital for the development of targeted therapies. As a leader in the biotechnology field, our company prides itself on offering high-quality genetic tools that empower the scientific community in their quest for innovation and discovery. Our expertise in gene editing technologies ensures that TMEM267 cell lines are optimized for performance, providing a solid foundation for groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.